Literature DB >> 21272932

Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity.

Frederico Pittella1, Mingzhen Zhang, Yan Lee, Hyun J Kim, Theofilus Tockary, Kensuke Osada, Takehiko Ishii, Kanjiro Miyata, Nobuhiro Nishiyama, Kazunori Kataoka.   

Abstract

Development of safe and efficient short interfering RNA (siRNA) delivery system for RNA interference (RNAi)-based therapeutics is a current critical challenge in drug delivery field. The major barriers in siRNA delivery into the target cytoplasm are the fragility of siRNA in the body, the inefficient cellular uptake, and the acidic endosomal entrapment. To overcome these barriers, this study is presenting a hybrid nanocarrier system composed of calcium phosphate comprising the block copolymer of poly(ethylene glycol) (PEG) and charge-conversional polymer (CCP) as a siRNA vehicle. In these nanoparticles, the calcium phosphate forms a stable core to incorporate polyanions, siRNA and PEG-CCP. The synthesized PEG-CCP is a non-toxic endosomal escaping unit, which induces endosomal membrane destabilization by the produced polycation through degradation of the flanking cis-aconitylamide of CCP in acidic endosomes. The nanoparticles prepared by mixing of each component was confirmed to possess excellent siRNA-loading efficiency (∼80% of dose), and to present relatively homogenous spherical shape with small size. With negligible cytotoxicity, the nanoparticles efficiently induced vascular endothelial growth factor (VEGF) mRNA knockdown (∼80%) in pancreatic cancer cells (PanC-1). Confocal laser scanning microscopic observation revealed rapid endosomal escape of siRNA with the nanoparticles for the excellent mRNA knockdown. The results obtained demonstrate our hybrid nanoparticle as a promising candidate to develop siRNA therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272932     DOI: 10.1016/j.biomaterials.2010.12.057

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  34 in total

Review 1.  Nanomedicine therapeutic approaches to overcome cancer drug resistance.

Authors:  Janet L Markman; Arthur Rekechenetskiy; Eggehard Holler; Julia Y Ljubimova
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

2.  Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.

Authors:  Guojun Chen; Yuyuan Wang; Ruosen Xie; Shaoqin Gong
Journal:  J Control Release       Date:  2017-02-01       Impact factor: 9.776

3.  Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery.

Authors:  Haijun Yu; Yonglong Zou; Yiguang Wang; Xiaonan Huang; Gang Huang; Baran D Sumer; David A Boothman; Jinming Gao
Journal:  ACS Nano       Date:  2011-11-01       Impact factor: 15.881

4.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 5.  Applications and perspectives of nanomaterials in novel vaccine development.

Authors:  Yingbin Shen; Tianyao Hao; Shiyi Ou; Churan Hu; Long Chen
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

Review 6.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

Review 7.  Particle-based technologies for osteoarthritis detection and therapy.

Authors:  Taylor E Kavanaugh; Thomas A Werfel; Hongsik Cho; Karen A Hasty; Craig L Duvall
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

8.  In vitro cytotoxicity of surface modified bismuth nanoparticles.

Authors:  Yang Luo; Chaoming Wang; Yong Qiao; Mainul Hossain; Liyuan Ma; Ming Su
Journal:  J Mater Sci Mater Med       Date:  2012-07-17       Impact factor: 3.896

Review 9.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

10.  Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Authors:  Yuning Zhang; Pontus Lundberg; Maren Diether; Christian Porsch; Caroline Janson; Nathaniel A Lynd; Cosimo Ducani; Michael Malkoch; Eva Malmström; Craig J Hawker; Andreas M Nyström
Journal:  J Mater Chem B       Date:  2015-03-28       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.